Andrew Wilson

Biography

A/P Wilson trained in Medicine and Cardiology at St Vincent’s Hospital and then completed a PhD in atherosclerosis research in the University of Melbourne, Department of Medicine. His clinical interests are in all areas of Interventional Cardiology and Assessment and Therapy of Cardiovascular Risk, particularly in high risk patients such as those with insulin resistance, renal disease and peripheral arterial disease. Andrew has previously worked at Stanford University Medical Center in California for 3 years training in Interventional Cardiology as well as working as an NHMRC Research Fellow focused on Translational Research in Atherosclerosis in the Falk Cardiovascular Research Institute at Stanford University. Andrew is currently appointed to the Departments of Cardiology and University Department of Medicine at St Vincent’s and the St Vincent’s Institute and is the Director of the University of Melbourne Lipid and Cardiovascular Risk Reduction Clinic. He is currently an NHF DART Clinical Research Fellow. He leads the Translational Cardiovascular Biology group and is involved in a range of projects focused on biomarkers of atherosclerosis and links between insulin resistance and cardiovascular disease. The role of the Chest Pain Assessment clinic is to provide streamlined assessment for patients with chest pain and cardiovascular risk and expedite access to diagnostic tests including coronary angiography, stress testing and the recently commenced cardic CT service.

Research Interest

Cardiovascular disease, coronary angiography, Atherosclerosis